A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Sotio Biotech Inc.
Incyte Corporation
Pfizer
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Sotio Biotech Inc.
Molecular Templates, Inc.
University of Florida
Fate Therapeutics
Eli Lilly and Company
National Cancer Institute (NCI)